MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2023 Earnings Call Transcript March 21, 2024
MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.15. INKT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good day everyone, and welcome to the MiNK Therapeutics’ Fourth Quarter 2023 Financial Results. Today’s call is being recorded. All lines have been placed on mute to...
